Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Myocardial Perfusion and Angina Improvement Following Allopurinol Therapy in a Patient With Coronary Artery Fistula
Sara D V Ziotti1, Renato P Azevedo2, Thiago L V Pereira3
1Centro de Pesquisa Clinica Prof. Fulvio Pileggi, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil; Unidade de Prevencao, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.
Insights
Coronary artery fistulas (CAFs) can cause angina. A high-dose allopurinol regimen improved symptoms and myocardial perfusion in a frail patient with CAFs unsuitable for intervention.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Coronary artery fistulas (CAFs) can cause myocardial ischemia and angina, even without obstructive coronary artery disease.
- Currently, no noninterventional strategies are proven to improve symptoms or ischemia in patients with refractory angina due to CAFs.
Observation:
- An 85-year-old woman with functional class 3 angina despite antianginal therapy presented with reversible left ventricular hypoperfusion.
- Coronary angiography revealed a CAF but no obstructive coronary artery disease.
Findings:
- The patient received high-dose allopurinol due to frailty and unsuitability for cardiac intervention.
- This treatment led to significant improvements in angina symptoms, exercise capacity, and myocardial perfusion.
Implications:
- Allopurinol may be a viable alternative treatment for ischemia and angina in patients with CAFs who are not candidates for traditional cardiac interventions.
- This case suggests a potential role for allopurinol in managing refractory angina associated with CAFs.
Background:
Coronary artery fistulas (CAFs) can lead to ischemia and angina in the absence of obstructive coronary artery disease. There is no evidence supporting a noninterventional approach to improve ischemia or alleviate symptoms for patients with refractory angina associated with CAFs.
Case Summary:
An 85-year-old woman presented with angina functional class 3 despite being on 3 antianginal medications. Myocardial scintigraphy showed reversible hypoperfusion in the left ventricle's lateral, inferolateral, and inferior walls. A coronary angiogram showed no obstructions; however, a CAF was found. Considering the patient's frailty and unsuitability for cardiac intervention, she was enrolled in a high-dose allopurinol protocol, which led to a significant improvement in symptoms, exercise capacity, and myocardial perfusion.
Discussion:
This case highlighted allopurinol as a potential alternative for alleviating ischemia and angina in patients with CAF deemed not good candidates for cardiac interventions.
Related Concept Videos
Angina IV: Management
Coronary Artery Disease V: Interprofessional Care
Angina V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

